超低出生体重児の管理マニュアル

出版社： メジカルビュー社
著者：
発行日： 2019-04-01
分野： 臨床医学：内科  >  周産期(新生児)
ISBN： 9784758317559
電子書籍版： 2019-04-01 （第1版第3版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

8,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

8,800 円(税込)

購入する

商品紹介

長野県立こども病院で行われている超低出生体重児の管理法を，漏れなく記載し，さらにそれをわかりやすく読者が理解できるように，Q&A，症例に基づくアルゴリズム・実際の管理法など多角的に解説された一冊。「看護の視点」も充実させ，チーム医療であるNICUの組織内の連携を補助できるものとなっている。

目次

  • I　 総論
    　1　超低出生体重児とは？
    　2　超低出生体重児診療に関する基本的な管理
    　3　超低出生体重児医療における倫理的対応
    　［コラム］273gの重み

    II　出生前・出生時の管理
    　1　出生前管理
    　2　出生・入院

    III　超低出生体重児によくみられる疾患とその管理・看護
    　1　呼吸
    　2　循環
    　3　神経
    　4　消化器
    　5　栄養
    　6　内分泌代謝
    　7　血液
    　8　黄疸（jaundice）
    　9　感染症
    　10　未熟児網膜症（retinopathy of prematurity；ROP）　 216
    　11　皮膚保護
    　12 ポジショニング（positioning）
    　13 退院前検査
    　14 退院調整

    IV　症例から考える管理
    　1　呼吸：呼吸窮迫症候群（respiratory distress syndrome；RDS）
    　2-a　循環：未熟児動脈管開存症（patent ductus arteriousus；PDA）
    　2-b　循環：新生児遷延性肺高血圧症
    　　　　　　　（persistent pulmonary hypertension of the newborn；PPHN）　
    　3　神経：脳室内出血および出血後水頭症
    　4-a　消化器：消化管穿孔
    　4-b　消化器：胃食道逆流症（gastroesophageal reflux disease；GERD）
    　5-a　内分泌代謝：高カリウム血症（hyper-kalemia）
    　5-b　内分泌代謝：甲状腺機能低下症（hypothyroidism）277
    　6　血液
    　7　黄疸（jaundice）
    　8　感染症：遅発型新生児敗血症（neonatal sepsis late onset sepsis）
    　　　（カテーテル血流感染）
    　9　皮膚保護

    V　フォローアップと予後
    　1　総論
    　2　長野県立こども病院のフォローアップ外来
    　3　フォローアップの実際

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

[I] 総論

P.10 掲載の参考文献
1) 胎児発育不全. 池田智明, 金山尚裕, 関沢明彦 編, 中外医学社, 東京, 2018, p12.
 
2) 厚生労働省政策統括官(統計・情報政策担当)平成29年 我が国の人口動態 平成27年までの動向. 厚生労働省, 2018.
 
3) 板橋家頭夫, 宮沢篤夫, 和田和子, ほか:日本小児科学会新生児委員会報告 2010年に出生した超低出生体重児の死亡率. 日児誌2016;120:1254-64.
 
4) Ishii N, Kono Y, Yonemoto N, et al:Outcomes of infants born at 22 and 23 weeks' gestation. Pediatrics 2013;132:62-71.
PubMed
5) 河野由美:周産期母子医療センターネットワークデータベース解析からみた極低出生体重児の予後. 日児誌 2014;118:613-22.
 
6) 河野由美:低出生体重児の発達障害. 医学のあゆみ 2017;260:231-6.
Medical*Online
P.14 掲載の参考文献
1) Uehara Y, Nakamura T, et al:H2O2 produced by viridans group streptococci may contribute to the inhibition of MRSA colonization in oral cavities of newborns. Clin Infect Dis 2001;32:1408-13.
 
2) Uehara Y, Nakamura T, et al:MRSA colonization inhibition in newborns' oral cavities by viridans group streptococci. Clin Infect Dis 2001;32:1399-407.
PubMed
3) Shimizu A, Shimizu K, Nakamura T:Non-pathogenic bacterial flora may inhibits colonization by methicillinresistant Staphylococcus aureus in extremely low birth weight infants. Neonatology 2008;93:158-61.
PubMed
4) 鈴木昭子, 中村友彦, 小宮山淳, ほか:超低出生体重児の上気道常在細菌叢と口腔内母乳塗布のMRSA保菌への影響. 日本小児科学会雑誌2003;107:480-3.
 
5) Lee J, Kim HS, et al:Oropharyngeal colostrum administration in extremely premature infants:An RCT. Pediatrics 2015;135:e357.
 
6) Filho FL, Sousa SHC, et al:Effect of maternal skin-to-skin contact on decolonization of Methicillin-Oxacillin-Resistant Staphylococcus in neonatal intensive care units:a randomized controlled trial. BMC Pregnancy & Childbirth 2015;15:63.
 
P.16 掲載の参考文献
1) 仁志田博司:周産期医療における臨床倫理学の奇跡 新生児・小児医療にかかわる人のための看取りの医療. 船戸正久, 鍋谷まこと 編, 診断と治療社, 東京, 2016, p21-34.
 
2) 厚生労働省・成育医療委託研究事業「重症障害新生児医療のガイドライン及びハイリスク新生児の診断システムに関する総合的研究」(主任研究者:田村正徳)平成13～15年研究報告書
 
3) 日本小児科学会倫理委員会小児終末期医療ガイドラインワーキンググループ 編:重篤な疾患を持つ子どもの医療をめぐる話し合いのガイドライン. 2012年. https://www.jpeds.or.jp/uploads/files/saisin_120808.pdf
 

[II] 出生前・出生時の管理

P.25 掲載の参考文献
1) 宮下 進, 中村友彦, 菊池昭彦:わが国の基幹周産期施設における早産, Small for gestational age 単胎児の出生状況と問題点. 周産期学シンポジウム2009;27:57-71.
 
2) Levine RJ, Maynard SE, Qian C, et al:Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.
PubMed
3) Kose S, Tuna G, Nuriyeva G, et al:A prospective cohort study on the prediction of the diagnosis-to-delivery time in preeclamptic pregnancies:should the sFlt-1/PlGF ratio be added to routine evaluations? Arch Gynecol Obstet 2018;298:911-20.
PubMed
4) Herraiz I, Simon E, Gomez-Arriaga PI, et al:Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction:A prospective cohort study. Pregnancy Hypertens 2018;13:279-85.
PubMed
5) Simon-Tillaux N, Lecarpentier E, Tsatsaris V, et al:Sildenafil for the treatment of preeclampsia, an update:should we still be enthusiastic? Nephrol Dial Transplant. 2018;doi:10.1093/ndt/gfy328.
 
6) 日本超音波医学会 用語・診断基準委員会:超音波胎児計測の標準化と日本人の基準値. 超音波医学 2003;30:416-40.
 
7) 板橋家頭夫:厚生科学研究費補助金(子ども家庭総合研究事業)「周産期母子医療センターネットワーク」による医療の質の評価と, フォローアップ・介入による改善・向上に関する研究 平成21年度分担研究報告書「日本人在胎期間別出生時体格基準値の 作成に関する研究(1)」. 2010年, p163-91.
 
8) Kaaij MW, Struijk PC, Lotgering FK:Accuracy of sonographic estimates of fetal weight in very small infants. Ultrasound Obstet Gynecol 1999;13:99-102.
PubMed
9) 改訂3版 超低出生体重児 新しい管理指針. 仁志田博司, 楠田 聡 編, メジカルビュー社, 東京, 2006年, p34.
 
10) Baschat AA:Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol 2011;37:501-14.
PubMed
11) 丸山有子, 茨 聡, 加藤博美, ほか:頭囲発育停止を指標にしたIUGR娩出のタイミング. 周産期学シンポジウム 2004;22:121-8.
 
12) 改訂3版 超低出生体重児 新しい管理指針. 仁志田博司, 楠田 聡 編, メジカルビュー社, 東京, 2006年, p35.
 
13) 宮下 進:超音波ドプラ法による評価と管理. 胎児発育不全. 中外医学社, 2018, pp107-15.
 
14) Moini A, Shiva M, Arabipoor A, et al:Obstetric and neonatal outcomes of twin pregnancies conceived by assisted reproductive technology compared with twin pregnancies conceived spontaneously:a prospective followup study. Eur J Obstet Gynecol Reprod Biol 2012;165:29-32.
PubMed
15) Tamaru S, Kikuchi A, Takagi K, et al:Neurodevelopmental outcomes of very low birth weight and extremely low birth weight infants at 18 months of corrected age associated with prenatal risk factors. Early Hum Dev 2011;87:55-9.
PubMed
16) Miyazaki C, Moreno Garcia R, Ota E, et al:Tocolysis for inhibiting preterm birth in extremely preterm birth, multiple gestations and in growth-restricted fetuses:a systematic review and meta-analysis. Reprod Health 2016;13:4.
PubMed
17) Saccone G, Ciardulli A, Xodo S, et al:CervicalPessary for Preventing Preterm Birth in Singleton Pregnancies With Short Cervical Length:A Systematic Review and Metaanalysis. J Ultrasound Med 2017;36:1535-43.
PubMed
18) WHO Recommendations on Interventions to Improve Preterm Birth Outcomes. Geneva, World Health Organization, 2015.
 
19) Savoy C, Ferro MA, Schmidt LA, et al:Prenatal betamethasone exposure and psychopathology risk in extremely low birth weight survivors in the third and fourth decades of life. Psychoneuroendocrinology. 2016;74:278-85.
PubMed
20) Ishikawa H, Miyazaki K, Ikeda T, et al;Neonatal Research Network of Japan:The Effects of Antenatal Corticosteroids on Short- and Long-Term Outcomes in Small-for-Gestational-Age Infants. Int J Med Sci 2015;12:295-300.
 
21) Committee on Infectious Diseases;Committee on Fetus and Newborn, Baker CJ, Byington CL, Polin RA:Policy statement - Recommendations for the prevention of perinatal group B streptococcal(GBS)disease. Pediatrics 2011;128:611-6.
 
22) Rovira N, Alarcon A, Iriondo M, et al:Impact of histological chorioamnionitis, funisitis and clinical chorioamnionitis on neurodevelopmental outcome of preterm infants. Early Hum Dev 2011;87:253-7.
PubMed
23) Vimercati A, Scioscia M, Panella E, et al:Perinatal risk factors and mode of delivery correlated to survival and psychomotor disability in extremely low birth weight infants. Gynecol Obstet Invest 2008;66:91-7.
PubMed
24) Haque KN, Hayes AM, Ahmed Z, et al:Caesarean or vaginal delivery for preterm very-low-birth weight(< or =1,250g)infant:experience from a district general hospital in UK. Arch Gynecol Obstet 2008;277:207-12.
 
25) Kallen K, Serenius F, Westgren M, et al:Impact of obstetric factors on outcome of extremely preterm births in Sweden:prospective population-based observational study(EXPRESS). Acta Obstet Gynecol Scand 2015;94:1203-14.
PubMed
26) Minguez-Milio JA, Alcazar JL, Auba M, Ruiz-Zambrana A, Minguez J:Perinatal outcome and long-term follow-up of extremely low birth weight infants depending on the mode of delivery. J Matern Fetal Neonatal Med 2011;24:1235-8.
PubMed
27) Manzoni P, Farina D, Maestri A, et al:Mode of delivery and threshold retinopathy of prematurity in pre-term ELBW neonates. Acta Paediatr 2007;96:221-6.
PubMed
28) Lorch SA, Baiocchi M, Ahlberg CE, et al:The differential impact of delivery hospital on the outcomes of premature infants. Pediatrics 2012;130:270-8.
PubMed
29) Kaneko M, Yamashita R, Kai K, et al:Perinatal morbidity and mortality for extremely low-birthweight infants:A population-based study of regionalized maternal and neonatal transport. J Obstet Gynaecol Res 2015;41:1056-66.
PubMed
30) Patel S, Clark EA, Rodriguez CE, et al:Effect of umbilical cord milking on morbidity and survival in extremely low gestational age neonates. Am J Obstet Gynecol 2014;211:519. e1-7.
 
31) Niermeyer S, Velaphi S:Promoting physiologic transition at birth:re-examining resuscitation and the timing of cord clamping. Semin Fetal NeonatalMed 2013;18:385-92.
PubMed
32) Guinsburg R, Branco de Almeida MF, Dos Santos Rodrigues Sadeck L, et al;Brazilian Network on Neonatal Research:Proactive management of extreme prematurity:disagreement between obstetricians and neonatologists. J Perinatol 2012;32:913-9.
PubMed
P.30 掲載の参考文献
1) AAP/AHA 新生児蘇生テキストブック. 田村正徳監訳, 医学書院, 東京, 2006, p.8-4.
 
P.38 掲載の参考文献
1) 日本版救急蘇生ガイドライン2015に基づく新生児蘇生法テキスト 第3版. 細野茂春 監, メジカルビュー社, 東京, 2016.
 
2) 第6章 新生児の一般的養護. 新生児学 第2版. 小川雄之亮, 多田 裕, 中村 肇, ほか編, メディカ出版, 大阪, 2000, p309.
 
3) AAP/AHA 新生児蘇生テキストブック. 田村正徳監訳, 医学書院, 東京, 2006, p8-4.
 
4) 改訂3版 超低出生体重児新しい管理指針. 仁志田博司, 楠田聡 編, メジカルビュー社, 東京, 2006.
 
P.43 掲載の参考文献
1) Avery's Diseases of the Newborn Ninth Edition. Gleason CA, Juul SE, eds, Saunders/Elsevere, 2011, p328.
 
2) 大野 勉:超低出生体重児の搬送. 周産期医学 1999;29:1284-5.
 
3) 白石 淳:超早産児の搬送. 周産期医学 2015;45:1303-5.
Medical*Online
4) 志賀清悟:新生児搬送. 周産期医学 2004;34:1211.
 
P.48 掲載の参考文献
1) Evans HE and Glass L:Thermoregulation. in Perinatal Medicine, ed Evans and Glass, Harper and Row Publisher, 1976.
 
2) Avery's Diseases of the Newborn Ninth Edition. Gleason CA, Juul SE eds, Saunders/Elsevere, 2011, p328.
 
3) 仁志田博司:新生児学入門 第3版. 医学書院, 東京, 2004, pp157-67.
 
4) 新版 新生児・未熟児の取り扱い. 奥山和男編, 診断と治療社, 東京, 1990.
 
5) Neonatology Pathophysiology and Management of the Newborn, 5th ed. Avery, GB, Fletcher, MA, MacDonald, MG eds, Lippincott Williams and Wilkins, Philadelphia, 1999, p.399.
 
6) 新版 新生児・未熟児の取り扱い. 奥山和男編, 診断と治療社, 東京, 1990, pp46-8.
 
7) ロバートン新生児集中治療マニュアル. 竹内 徹監訳, メディカ出版, 大阪, 2003, p.10.
 
8) Laptook AR, Salhab W, Bhaskar B:Neonatal Research Network:Admission temperature of low birth weights infants:predictors and associated morbidities. Pediatrics 2007;119:634-9.
 
9) 白井憲司, 加藤丈典:蘇生の初期処置. 日本版救急蘇生ガイドライン2015 に基づく新生児蘇生法テキスト 第3版, 細野茂春 監, メジカルビュー社, 東京, 2016, p.50.
 
10) Chapter 31 Acid-Base, Fluid and Electrolyte Management. In;Avery's Diseases of the Newborn Ninth Edition, Gleason CA, Devaskar S eds, Saunders/Elsevere, 2011, p.371
 

[III] 超低出生体重児によくみられる疾患とその管理・看護

P.56 掲載の参考文献
1) NICUマニュアル第4版. 新生児医療連絡会編, 金原出版, 東京, 2007, p.143.
 
2) Isayama T, Iwami H, McDonald S et al:Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants:ASystematic Review and Meta-analysis. JAMA 2016;316:611-24.
 
P.60 掲載の参考文献
1) Avery's Neonatology, 7th ed. MacDonald MG, Seshia MMK, eds, Wolters Kluwer, 2016, p.388-9.
 
2) Sreenan C, Ire M, Lemke RP, et al:High-Flow Nasal Cannulae in the Management of Apnea of Prematurity:A Comparison With Conventional Nasal Continuous Positive Airway Pressure. Pediatrics 2001;107:1081-3.
 
3) Manley BJ, Dold SK, Davis PG, et al:High-flow nasal cannulae for respiratory support of preterm infants:A review of the evidence. Neonatology 2012;102:300-8.
PubMed
4) Schmidt B, Roberts RS, Davis P, et al:Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354:2112-21.
PubMed
5) Schmidt B, Anderson PJ, Doyle LW, et al:Survival Without Disability to Age 5 Years for Apnea of Prematurity. JAMA 2012;307:275-82.
PubMed
P.66 掲載の参考文献
1) Rastogi S, Gupta A, Wung JT, et al:Treatment of giant pulmonary interstitial emphysema by ipsilateral bronchial occlusion with a Swan-Ganz catheter. Pedoatr Radiol 2007;37:1130-4.
PubMed
2) Laptook AR, O'Shea TM, Shankaran S, et al:Adverse neurodevelopmental outcomes among extremely low birth weight infants with a normal head ultrasound:prevalence and antecedents. Pediatrics 2005;115:673-80.
PubMed
3) Miller JD, Carlo WA:Pulmonary complications of mechanical ventilation in neonates. Clin Perinatol 2008;35:273-81.
PubMed
P.72 掲載の参考文献
1) 改訂第2版 科学的根拠に基づいた新生児慢性肺疾患の診療指針. 藤村正哲 監, 森臨太郎, 田村正徳 編, メディカ出版, 大阪, 2010, p5.
 
2) Walsh MC, Yao Q, Gettner P, et al:Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates. Pediatrics 2004;114:1305-11. Available from:http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2004-0204
 
3) Poindexter BB, Feng R, Schmidt B, et al:Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc. 2015;12:1822-30.
PubMed
4) Isayama T, Lee SK, Yang J, et al:Revisiting the Definition of Bronchopulmonary Dysplasia. JAMA Pediatr 2017;171:271-9. Available from:http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/jamapediatrics.2016.4141
 
5) Nakamura T, Yonemoto N, Nakayama M, et al:Early inhaled steroid use in extremely low birthweight infants:a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2016:101:F552-6.
PubMed
6) Gupta S, Sinha SK, Donn SM:Ventilatory management and bronchopulmonary dysplasia in preterm infants. Semin Fetal Neonatal Med. 2009;14:367-73. Available from:http://www.ncbi.nlm.nih.gov/pubmed/19766071
 
P.74 掲載の参考文献
1) Porat S, Amsalem H, Shah PS, et al:Transabdominal amnioinfusion for preterm premature rupture of membranes:a systematic review and metaanalysis of randomized and observational studies. Am J Obstet Gynecol 2012;207:393. e1-11
 
P.78 掲載の参考文献
1) El-Khuffash A, McNamara PJ:Hemodynamic Assessment and Monitoring of Premature Infants. Clin Perinatol 2017;44:377-93
 
2) Nakanishi T, Okuda H, Kamata K et al:Development of myocardial contractile system in the fetal rabbit. Pediatr Res 1987;22:201-7.
PubMed
3) 中西敏雄:心筋細胞とCa制御機構の発達. 心臓 2014;46:150-5.
Medical*Online
4) Friedman WF:The intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis 1972;15:87-111.
PubMed
5) Romero TE, Friedman WF:Limited left ventricular response to volume overload in the neonatal period:a comparative study with the adult animal. Pediatr Res 1979;13:910-5.
PubMed
6) Takahashi Y, Harada K, Kishkurno S, et al:Postnatal left ventricular contractility in very low birth weight infants. Pediatr Cardiol 1997;18:112-7.
PubMed
7) Takahashi Y, Harada K, Ishida A, et al:Left ventricular preload reserve in preterm infants with patent ductus arteriosus. Arch Dis Child 1994;71:F118-21.
PubMed
8) Ng PC:Adrenocortical insufficiency and refractory hypotension in preterm infants. Arch Dis Child Fetal Neonatal Ed 2016;101:F571-6.
PubMed
9) Evans K:Cardiovascular Transition of the Extremely Premature Infant and Challenges to Maintain Hemodynamic Stability. J Perinat Neonatal Nurs 2016;30:68-72.
PubMed
P.84 掲載の参考文献
1) Jain A, Shah PS:Diagnosis, Evaluation, and Management of Patent Ductus Arteriosus in Preterm Neonates. JAMA Pediatr 2015:169:863-72.
PubMed
2) El Hajjar M, Vaksmann G, Rakza T, et al:Severity of the ductal shunt:a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 2005;90:F419-22.
PubMed
3) van Laere D, van Overmeire B, Gupta S, et al:Application of NPE in the assessment of a patent ductus arteriosus. Pediatr Res 2018;(suppl 1):46-56.
 
4) Saida K, Nakamura T, Hiroma T, et al:Preoperative left ventricular internal dimension in end-diastole as earlier identification of early patent ductus arteriosus operation and postoperative intensive care in very low birth weight infants. Early Hum Dev 2013;89:821-3.
PubMed
P.88 掲載の参考文献
1) Nair J, Lakshminrusimha S:Update on PPHN:mechanisms and treatment. Semin Perinatol 2014;38:78-91.
PubMed
2) Steinhorn RH:Advances in Neonatal Pulmonary Hypertension. Neonatology 2016;109:334-44.
PubMed
3) Kinsella JP, Ivy DD, Abman SH:Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatric Research 1994;36:402-8.
PubMed
4) Kumar VH, Hutchison AA, Lakshminrusimha S, et al:Characteristics of pulmonary hypertension in preterm neonates. J Perinatol 2007;27:214-9.
PubMed
5) Dani C, Corsini I, Cangemi J, et al:Nitric oxide for the treatment of preterm infants with severe RDS and pulmonary hypertension. Pediatr Pulmonol 2017;52:1461-8.
PubMed
6) de Boode WP, Singh Y, Molnar Z, et al:Application of Neonatologist Performed Echocardiography in the assessment and management of persistent pulmonary hypertension of the newborn. Pediatr Res 2018;84(Suppl 1):68-77.
 
7) Barrington KJ, Finer N, Pennaforte T, et al:Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017;1:CD000399.
PubMed
8) Barrington KJ, Finer N, Pennaforte T:Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2017;1:CD000509.
PubMed
9) Baczynski M, Ginty S, Weisz DE, et al:Short-term and longterm outcomes of preterm neonates with acute severe pulmonary hypertension following rescue treatment with inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed 2017;102:F508-14.
PubMed
10) Van Meurs KP, Wright LL, Ehrenkranz RA, et al:Preemie Inhaled Nitric Oxide Study. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 2005;353:13-22.
PubMed
P.92 掲載の参考文献
1) Costello JM, Mazwi ML, McBride ME, et al:Critical care for paediatric patients with heart failure. Cardiol Young 2015;25:74-86.
PubMed
2) 齋木宏文, 先崎秀明:新生児期循環不全の管理. 周産期医学2011;41:81-5.
 
3) Mahony L:Maturation of calcium transport in cardiac sarcoplasmic reticulum. Pediatr Res 1988;24:639-43.
PubMed
4) Romero TE, Friedman WF:Limited left ventricular response to volume overload in the neonatal period:a comparative study with the adult animal. Pediatr Res 1979;13:910-5.
PubMed
5) Lebowitz EA, Novick JS, Rudolph AM:Development of myocardial sympathetic innervation in the fetal lamb. Pediatr Res 1972;6:887-93.
PubMed
6) Cox DJ, Groves AM:Inotropes in preterm infants--evidence for and against. Acta Paediatr 2012;101:17-23.
PubMed
7) Takahashi Y, Harada K, Kishkurno S, et al:Postnatal left ventricular contractility in very low birth weight infants. Pediatr Cardiol 1997;18:112-7.
PubMed
8) Toyoshima K, Kawataki M, Ohyama M, et al:Tailor-made circulatory management based on the stress-velocity relationship in preterm infants. J Formos Med Assoc 2013;112:510-7.
PubMed
P.96 掲載の参考文献
1) Masumoto K, Kusuda S, Aoyagi H, et al:Comparison of serum cortisol concentrations in preterm infants with or without late-onset circulatory collapse due to adrenal insufficiency of prematurity. Pediatr Res 2008;63:686-90.
PubMed
2) Kawai M, Kusuda S, Cho K, et al:Nationwide surveillance of circulatory collapse associated with levothyroxine administration in very-low-birth weight infants in Japan. Pediatr Int 2012;54:177-81.
PubMed
3) Washio Y, Uchiyama A, Nakanishi H, et al:Hemodynamic analysis in infants with late-onset circulatory collapse. Pediatr Int 2013;55:582-8.
PubMed
4) Kobayashi S, Fujimoto S, Koyama N, et al:Late-onset circulatory dysfunction of premature infants and late-onset periventricular leukomalacia. Pediatr Int 2008;50:225-31.
PubMed
5) Kawai M:Late-onset circulatory collapse of prematurity. Pediatr Int 2017;59:391-6.
PubMed
6) Nakanishi H, Yamanaka S, Koriyama T, et al:Clinical characterization and long-term prognosis of neurological development in preterm infants with late-onset circulatory collapse. J Perinatol 2010;30:751-6.
PubMed
P.99 掲載の参考文献
1) Ishii N, Kono Y, Yonemoto N, et al:Neonatal Research Network, Japan. Outcomes of infants born at 22 and 23 weeks' gestation. Pediatrics 2013;132:62-71.
 
2) Kono Y, Mishina J, Yonemoto N, et al:Neonatal correlates of adverse outcomes in very low-birthweight infants in the NICU Network. Pediatr Int 2011;53:930-5.
PubMed
3) Sarkar S, Bhagat I, Dechert R, et al:Severe intraventricular hemorrhage in preterm infants:comparison of risk factors and short-term neonatal morbidities between grade 3 and grade 4 intraventricular hemorrhage. Am J Perinatol 2009;26:419-24.
PubMed
4) Bolisetty S, Dhawan A, Abdel-Latif M, et al:Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics 2014;133:55-62.
PubMed
5) Inder TE, Huppi PS, Warfield S, et al:Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol 1999;46:755-60.
PubMed
6) Iwata S, Nakamura T, Hizume E, et al:Qualitative brain MRI at term and cognitive outcomes at 9 years after very preterm birth. Pediatrics 2012;129:e1138-47.
PubMed
7) Kidokoro H, Anderson PJ, Doyle LW, et al:Brain injury and altered brain growth in preterm infants:predictors and prognosis. Pediatrics 2014;134:e444-53.
PubMed
8) Woodward LJ, Anderson PJ, Austin NC, et al:Neonatal MRI to Predict Neurodevelopmental Outcomes in Preterm Infants. N Engl J Med 2006 17;355:685-94.
PubMed
9) 儀間裕貴, 木原秀樹, 中村友彦:極低出生体重児に対する Dubowitz 神経学的評価と修正6歳時点の発達の関係. 日本周産期・新生児医学会雑誌 2015;51:981-8.
Medical*Online
10) Novak I, Morgan C, Adde L, et al:Early, Accurate Diagnosis and Early Intervention in Cerebral Palsy:Advances in Diagnosis and Treatment. JAMA Pediatr 2017;171:897-907.
PubMed
P.103 掲載の参考文献
1) Ment LR, Stewart WB, Duncan CC, et al:Beagle puppy model of intraventricular hemorrhage. J Neurosurg 1982;57:219-23.
PubMed
2) Kaiser JR, Gauss CH, Williams DK:Surfactant administration acutely affects cerebral and systemic hemodynamics and gas exchange in very-low-birth-weight infants. J Pediatr 2004;144:809-14.
PubMed
3) Volpe J:Neurology of the newborn, ed 5. WB Saunders, Philadelphia, 2008.
 
4) Ment LR, Schneider K:Intraventricular hemorrhage of the preterm infant. Semin Neurol 1993;13:40-7.
PubMed
5) Papile LA, Burstein J, Burstein R, et al:Incidence and evolution of subependymal and intraventricular hemorrhage:a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
PubMed
6) Roberts D, Brown J, Medley N, et al:Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017;3:CD004454.
PubMed
7) Moriette G, Paris-Llado J, Walti H, et al:Prospective randomized multicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome. Pediatrics 2001;107:363-72.
PubMed
8) Schmidt B, Davis P, Moddemann D, et al:Trial of Indomethacin Prophylaxis in Preterms Investigators. Longterm effects of indomethacin prophylaxis in extremely-lowbirth-weight infants. N Engl J Med 2001;344:1966-72.
 
9) Al-Wassia H, Shah PS:Efficacy and safety of umbilical cord milking at birth:a systematic review and meta-analysis. JAMA Pediatr 2015;169:18-25.
PubMed
P.106 掲載の参考文献
1) Whitelaw A, Lee-Kelland R:Repeated lumbar or ventricular punctures in newborns with intraventricular haemorrhage. Cochrane Database Syst Rev 2017;4:CD000216.
PubMed
2) Kennedy CR, Ayers S, Campbell MJ, et al:Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy:follow-up at 1 year. Pediatrics 2001;108:597-607.
PubMed
P.110 掲載の参考文献
1) Khwaja O, Volpe JJ:Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008;93:F153-61.
PubMed
2) Volpe JJ:Cerebral white matter injury of the premature infant-more common than you think. Pediatrics 2003;112(1 Pt 1):176-80.
 
3) Volpe JJ:Nuerology of the newborn 5th ed. W.B.Saunders, Philadelphia, 2008.
 
4) Ment LR, Bada HS, Barnes P, et al:Practice parameter:neuroimaging of the neonate:report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002;58:1726-38.
 
5) Inder T, Huppi PS, Zientara GP, et al:Early detection of periventricular leukomalacia by diffusion-weighted magnetic resonance imaging techniques. J Pediatr 1999;134:631-4.
PubMed
6) Barkovich AJ:Concepts of myelin and myelination in neuroradiology. AJNR Am J Neuroradiol 2000;21:1099-109.
PubMed
P.113 掲載の参考文献
1) Murray DM, Boylan GB, All I, et al:Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 2008;93:F187-91.
PubMed
2) 奥村彰久, 新島新一, 渡邊一功:新生児けいれんの診断と治療 -その問題点-. 脳と発達2008;40:228-30.
 
3) 奥村 彰久:新生児発作. 周産期医学必修知識 Vol.46 増刊号. 2016:700-2.
 
4) Clancy RR:Summary proceedings from the neurology group on neonatal seizures. Pediatrics 2006;117:S23-7.
 
5) Glass HC, Shellhaas RA, Tsuchida TN, et al:Seizures in Preterm Neonates:A Multicenter Observational Cohort Study. Pediatr Neurol 2017;72:19-24.
 
6) 孫田みゆき:新生児発作. Neonatal Care 2014;27:553.
 
7) Lloyd RO, O'Toole JM, Pavlidis E, et al:Electrographic seizures during the early postnatal period in preterm infants. J Pediatr 2017;187:18-25.
PubMed
8) Shah DK, Mackay MT, Laver S, et al:Accuracy of bedside electroencephalographic monitoring in comparison with simultaneous Continuous conventional electroencephalography for seizure detection in term infants. Pediatrics 2008;121:1146-54.
 
9) Evans E, Koh S, Lerner J, et al:Accuracy of amplitude integrated EEG in a neonatal cohort. Arch Dis Child Fetal Neonatal Ed 2010;95:F169-73.
 
10) Shellhaas RA, Chang T, Wusthoff CJ, et al:Treatment Duration After Acute Symptomatic Seizures in Neonates:A Multicenter Cohort Study. J Pediatr 2017;181:298-301.
PubMed
11) Uria-Avellanal C, Marlow N, Rennie JM:Outcome following neonatal seizures. Semin Fetal Neonatal Med 2013;18:224-32.
PubMed
P.116 掲載の参考文献
1) 日本小児外科学会学術・先進医療検討委員会, 新生児フォーラム:超低出生体重児における消化管穿孔の実態調査. 日小外会誌 2010;40:791-6.
 
2) Clark RH, Thomas P, Peabody J:Extra uterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics. 2003;111(5 Pt 1):986-90.
 
3) 厚生労働科学研究費補助金, 難治性疾患等克服研究事業, 総括研究報告書 低出生体重児の消化管機能障害に関する周産期背景因子の疫学調査研究 平成25年度総括・分担研究報告書. 2014.
 
4) Ishii N, Kono Y, Yonemoto N, et al:Neonatal Research Network, Japan. Outcomes of infants born at 22 and 23 weeks' gestation. Pediatrics 2013;132:62-71.
 
5) Nutritional Care of Preterm Infants:Scientific Basis and Practical Guidelines. World Rev Nutr Diet. vol 110. Koletzko B, Poindexter B, Uauy R, eds, Basel, Karger, 2014, pp201-14.
 
6) Dsilna A, Christensson K, Alfredsson L, et al:Continuous feeding promotes gastrointestinal tolerance and growth in very low birth weight infants. J Pediatr 2005;147:43-9.
PubMed
7) Flidel-Rimon O, Branski D, Shinwell ES:The fear of necrotizing enterocolitis versus achieving optimal growth in preterm infants--an opinion. Acta Paediatr 2006;95:1341-4.
PubMed
8) Wemhoner A, Ortner D, Tschirch E, et al:Nutrition of preterm infants in relation to bronchopulmonary dysplasia. BMC Pulm Med 2011;11:7.
PubMed
9) Stephens BE, Walden RV, Gargus RA, et al:First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics 2009;123:1337-43.
PubMed
10) Butler TJ, Szekely LJ, Grow JL:A standardized nutrition approach for very low birth weight neonates improves outcomes, reduces cost and is not associated with increased rates of necrotizing enterocolitis, sepsis or mortality. J Perinatol 2013;33:851-7.
PubMed
11) Stefanescu BM, Gillam-Krakauer M, Stefanescu AR, et al:Very low birth weight infant care:adherence to a new nutrition protocol improves growth outcomes and reduces infectious risk. Early Hum Dev 2016;94:25-30.
PubMed
12) Cristofalo EA, Schanler RJ, Blanco CL, et al:Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr 2013;163:1592-5. e1.
 
13) Warner BB, Deych E, Zhou Y, et al:Gut bacteria dysbiosis and necrotizing enterocolitis in very low birthweight infants:a prospective case-control study. Lancet 2016;387:1928-36.
PubMed
14) Cotten CM, Taylor S, Stoll B, et al:NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58-66.
 
15) Kitajima H, Sumida Y, Tanaka R, et al:Early administration of Bifidobacterium breve to preterm infants:randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 1997;76:F101-7.
PubMed
16) Dermyshi E, Wang Y, Yan C, et al:The "Golden Age" of Probiotics:A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants. Neonatology 2017;112:9-23.
 
P.122 掲載の参考文献
1) Kasivajjula H, Maheshwari A:Pathophysiology and current management of necrotizing enterocolitis. Indian J Pediatr 2014;81:489-97.
PubMed
2) Nowicki PT:Ischemia and necrotizing enterocolitis:where, when, and how. Semin Pediatr Surg 2005;14:152-8.
PubMed
3) Stoll BJ, Kanto WP Jr, Glass RI, et al:Epidemiology of necrotizing enterocolitis:a case control study. J Pediatr 1980;96(3 Pt 1):447-51.
 
4) Watkins DJ, Besner GE:The role of the intestinal microcirculation in necrotizing enterocolitis. Semin Pediatr Surg 2013;22:83-7.
PubMed
5) Gewolb IH, Schwalbe RS, Taciak VL, et al:Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999;80:F167-73.
PubMed
6) Warner BB, Deych E, Zhou Y, et al:Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants:a prospective case-control study. Lancet 2016;387:1928-36.
PubMed
7) Cotten CM, Taylor S, Stoll B, et al;NICHD Neonatal Research Network:Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58-66.
 
8) Guillet R, Stoll BJ, Cotten CM, et al:Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006;117:e137-42.
PubMed
9) Meng D, Zhu W, Shi HN et al:Toll-like receptor-4 in human and mouse colonic epithelium is developmentally regulated:a possible role in necrotizing enterocolitis. Pediatr Res 2015;77:416-24.
PubMed
10) Gribar SC, Sodhi CP, Richardson WM, et al:Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol 2009;182:636-46.
PubMed
11) Claud EC, Lu L, Anton PM, et al:Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Send to Proc Natl Acad Sci U S A 2004;101:7404-8.
 
12) Caplan M, Hsueh W, Kelly A, et al:Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 1990;39:705-14.
PubMed
13) Shin CE, Falcone RA Jr, Stuart L, et al:Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 2000;35:173-6;discussion 177.
PubMed
14) Besner GE:A pain in the NEC:research challenges and opportunities. J Pediatr Surg 2015;50:23-9.
PubMed
15) Walsh MC, Kliegman RM, Fanaroff AA:Necrotizing enterocolitis:a practitioner's perspective. Pediatr Rev 1988;9:219-26.
PubMed
16) Hull MA, Fisher JG, Gutierrez IM, et al:Mortality and management of surgical necrotizing enterocolitis in very low birth weight neonates:a prospective cohort study. J Am Coll Surg 2014;218:1148-55.
PubMed
17) Molik KA, West KW, Rescorla FJ, et al:Portal venous air:the poor prognosis persists. J Pediatr Surg 2001;36:1143-5.
PubMed
18) Shah D, Sinn JK:Antibiotic regimens for the empirical treatment of newborn infants with necrotising enterocolitis. Cochrane Database Syst Rev 2012;(8):CD007448.
PubMed
19) Moss RL, Dimmitt RA, Barnhart DC, et al:Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation. N Engl J Med 2006;354:2225-34.
PubMed
20) Rees CM, Eaton S, Kiely EM, et al:Peritoneal drainage or laparotomy for neonatal bowel perforation? A randomized controlled trial. Ann Surg 2008;248:44-51.
 
21) Vaughan WG, Grosfeld JL, West K, et al:Avoidance of stomas and delayed anastomosis for bowel necrosis:the "clip and drop-back" technique. J Pediatr Surg 1996;31:542-5.
PubMed
22) Nose S, Sasaki T, Saka R, et al:A sutureless technique using cyanoacrylate adhesives when creating a stoma for extremely low birth weight infants. Springerplus 2016;5:189.
PubMed
23) Fitzgibbons SC, Ching Y, Yu D, et al:Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009;44:1072-5;discussion 1075-6.
 
24) Heida FH, Loos MH, Stolwijk L, et al:Risk factors associated with postnecrotizing enterocolitis strictures in infants. J Pediatr Surg 2016;51:1126-30.
PubMed
P.126 掲載の参考文献
1) 奥山宏臣ほか;日本小児外科学会, 日本周産期・新生児医学会極低出生体重児の消化管機能障害診療ガイドライン作成事務局編:極低出生体重児の消化管機能障害診療ガイドライン. 平成26-27年度厚生労働科学研究費補助金(難治性疾患克服研究事業)"低出生体重児消化管機能障害の疾患概念確立にむけた疫学研究". 2016.
 
2) 窪田昭男, 井村賢治, 小林 敬, ほか:周産期センターにおける胎便関連性腸閉塞症例の検討. 日本新生児学会雑誌 1995;31:120-7.
 
3) Casaccia G, Trucchi A, Nahom A, et al:The impact of cystic fibrosis on neonatal intestinal obstruction:the need for prenatal/neonatal screening. Pediatr Surg Int 2003;9:75-8.
PubMed
4) Kubota A, Shiraishi J, Kawahara H, et al:Meconium-related ileus in extremely low-birthweight neonates:Etiological considerations from histology and radiology. Pediatrics International 2011;53:887-91.
PubMed
5) 奥山宏臣, 佐々木隆士, 清水義之, ほか:低出生体重児における胎便関連性腸閉塞. 小児外科 2011;41:1191-5.
 
6) Garza-Cox S, Keeney SE, Angel CA, et al:Meconium obstruction in the very low birth weight premature infant. Pediatrics 2004;114:285-90.
PubMed
7) 鈴木 完, 仁科孝子, 村越孝次, ほか:極低出生体重児に発症した胎便排泄遅延に対する造影剤治療の検討(早期に開始することの有効性について). 日本周産期・新生児医学会雑誌 2007;43:56-61.
Medical*Online
8) 武 浩志, 大浜用克, 北河徳彦, ほか:胎便関連性腸閉塞症に対する治療法と治療成績. 日本周産期・新生児医学会雑誌 2008;44:948-52.
Medical*Online
9) 竹内 敏, 中平三士, 平林 円, ほか:ヨード過剰による一過性甲状腺機能低下症を呈した新生児外科症例の経験. 日本小児外科学会雑誌 1994;30:749-54.
 
10) 寺田明佳, 市場博幸, 郡山 健, ほか:極低出生体重児の胎便関連性腸閉塞症に対するガストログラフィン胃内投与の効果. 日本未熟児新生児学会雑誌 2007;19:85-88.
 
11) Michikata K, Kodama Y, Kaneko M, et al:Oral diatrizoate acid for meconium-related ileus in extremely preterm infants. Pediatr Int 2018;60:714-8.
PubMed
P.133 掲載の参考文献
1) Korai T, Kouchi K, Takenouchi A, et al:Neonates undergoing gastrointestinal surgery have a higher incidence of non-IgE-mediated gastrointestinal food allergies. Pediatr Surg Int 2018;34:1009-1017. Available from:http://www.ncbi.nlm.nih.gov/pubmed/30109413
 
2) 新生児-乳児消化管アレルギー(新生児-乳児食物蛋白誘発胃腸炎)診断治療指針. 厚生労働省難治性疾患研究班 新生児-乳児アレルギー疾患研究会 日本小児栄養消化器肝臓病学会ワーキンググループ編, 2016年1月12日改訂. http://nrichd.ncchd.go.jp/imal/FPIES/icho/pdf/fpies.pdf
 
P.137 掲載の参考文献
1) 大塩猛人:乳児臍ヘルニア絆創膏固定法10年間513症例の検討. 小児外科 2012;44:389-94.
Medical*Online
2) 大塩猛人:乳児期の臍ヘルニアの対応. 外来小児科 2017;20:308-12.
 
P.141 掲載の参考文献
1) Rosen R, Vandenplas Y, Singendonk M, et al:Pediatric Gastroesophageal Reflux Clinical Practice Guidelines. J Pediatr Gastroenterol Nutr 2018;66:516-54.
PubMed
2) Clifford P, Ely E, Heimall L:Bedside Placement of the Postpyloric Tube in Infants. Adv Neonatal Care 2017;17:19-26.
 
3) Long HA, Solski L, Rebuck JA, et al:Infantile Gastroesophageal Reflux:Adherence to Treatment Guidelines in the Hospital Setting. J Pediatr Pharmacol Ther 2018;23:41-7.
PubMed
P.142 掲載の参考文献
1) Ziegler EE, Thureen PJ, Carlson SJ, et al:Aggressive nutrition of the very low birth weight infant. Clin Perinatol 2002;29:225-44.
PubMed
2) Denne SC, Poindexter BB:Evidence supporting early nutritional support with parenteral amino acid infusion. Semin Perinatol 2007;31:56-60.
PubMed
3) Uauy R, Dangour AD:Nutrition in brain development and aging;role of essential fatty acids. Nutr Rev 2006;64:S24-33.
PubMed
P.148 掲載の参考文献
1) 市橋 寛:新生児臨床研究ネットワークによる多施設ランダム化比較試験 - 超低出生体重児における超早期授乳. 周産期医学 2013;43:591-5.
Medical*Online
2) Ahrabi AF, Schanler RJ:Human milk is the only milf for premies in the NICU! Early Hum Dev 2013;89(suppl 2):S51-3.
 
3) Cristofalo EA, Schanler RJ, Blanco CL, et al:Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr 2013;163:1592-5.
PubMed
P.154 掲載の参考文献
1) Cornblath M, Hawdon JM, Williams AF, et al:Controversies regarding definition of neonatal hypoglycemia:suggested operational thresholds. Pediatrics 2000;105:1141-5.
PubMed
2) Boluyt N, van Kempen A, Offringa M:Neurodevelopment after neonatal hypoglycemia:a systematic review and design of an optimal future study. Pediatrics 2006;117:2231-43.
PubMed
3) 先天性高インスリン血症診療ガイドライン. 病因・病態・診断. 日本小児内分泌学会・日本小児外科学会編, 2016, p9.
 
P.168 掲載の参考文献
1) 仁志田博司:血液系の病態と臨床. 新生児学入門 第4版. 医学書院, 東京, 2012, p316-31.
 
2) Bizzarro MJ, Colson E, Ehrenkranz RA:Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51:1087-107.
PubMed
3) 仁志田博司:安定同位元素50Crを用いた新生児血流量・赤血球量の測定. 座位分娩, 仰臥位分娩, 帝切分娩における比較検討. 日新生児会誌1986;21:70.
 
4) Bizzarro MJ, Colson E, Ehrenkranz RA:Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51:1087-107.
PubMed
5) Nathan and Oski's Hematology and Oncology of Infancy and Childhood 8th ed. Orkin S, Nathan D, Ginsburg D, et al eds, Saunders, 2014, p.57.
 
P.171 掲載の参考文献
1) Cunningham FG, Hollier LM:Fetal death. Williams Obstetrics, 20th ed (Suppl 4), Appleton & Lange, Norwalk, 1997.
 
2) Nathan and Oski's Hematology and Oncology of Infancy and Childhood 8th edition. Orkin S, Nathan D, Ginsburg D, et al eds, Saunders, 2014, p57.
 
3) Giacoia GP:Severe fetomatermal hemorrhage:a review. Obstet Gynecol Surv 1997;52:372-80.
PubMed
P.175 掲載の参考文献
1) 新生児医療連絡会編:NICUマニュアル第5版. 金原出版, 東京, 2014.
 
2) Nagano N, Saito M, Sugiura T, et al:Benefits of umbilical cord milking versus delayed cord clamping on neonatal outcomes in preterm infants:A systematic review and meta-analysis PLoS One. 2018 Aug 30;13:e0201528.
 
3) 日本新生児成育医学会 医療の標準化委員会内 鉄剤補充ガイドライン作成小委員会編:新生児に対する鉄剤投与ガイドライン2017(案). http://jsnhd.or.jp/pdf/pblcmt/pbl00301.pdf
 
4) 血液製剤の使用指針. VII 新生児・小児に対する輸血療法1. 新生児・小児に対する赤血球液の適正使用. 厚生労働省医薬・生活衛生局. 平成30年9月. https://www.mhlw.go.jp/content/11127000/000361950.pdf
 
P.179 掲載の参考文献
1) 宮崎澄雄:標準処方ガイド'96 新生児溶血性貧血. 治療1996;78(supple):1170-2.
 
2) 大戸 斉:6 血液型母児不適合妊娠. 小児輸血学, 大戸 斉, ほか編, 中外医学社, 東京, 2006, 84-100.
 
P.184 掲載の参考文献
1) 白幡 聡:乳児ビタミンK欠乏症の全国調査, 岩永貞明他編 ビタミンK-医学・生物学領域における新展開 メディカル・ジャーナル社 1994:367-74.
 
2) Nelson Textbook of Pediatrics 20th ed. Kleigman RM, Stanton BF, St. Geme JWIII, et al (eds), p888, Elsevier, 2015.
 
3) Sutor AH:New aspects of vitamin K prophylaxis. Semin Thromb Hemost 2003;29:373-6.
PubMed
4) 日本小児科学会新生児委員会ビタミンK投与法の見直し小委員会:新生児・乳児ビタミンK欠乏性出血症に対するビタミンK製剤投与の改訂ガイドライン(修正版). 2011.
 
5) Hansen KN, Minousis M, Ebbesen F:Weekly oral vitamin K prophylaxis in Denmark. Acta Paediatr 2003;92:802-5.
PubMed
P.190 掲載の参考文献
1) 白幡 聡, 高橋幸博, 茨 聡, ほか;日本産婦人科・新生児血液学会新生児DIC診断・治療指針作成ワーキンググループ:新生児DIC診断・治療指針2016年版. 日本産婦人科・新生児血液学会誌 2016;25:3-34. http://www.jsognh.jp/common/files/society/2017/guideline_2016.pdf
 
2) Andrew M:The hemostatic system in the infant. Hematology of infancy and children 4th ed. Nathan DG and Oski FA eds, WB Saunders, Philadelphia, 1992, 115-53.
 
3) 長江干愛, 瀧 正志:小児科領域におけるDIC診断の留意点. Thrombosis Medicine 2015;5:32-8.
Medical*Online
4) 高橋大二郎, 松井美優, 齋藤玲子, ほか:出生体重別にみた新生児の蛋白産生能と凝固学的検査値の相関. 日本周産期・新生児医学会誌 2009;45:1456-60.
 
5) Omote M, Asakura H, Takamichi S, et al:Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers. Thromb Res 2008;123:390-5.
PubMed
P.193 掲載の参考文献
1) 中村 肇, 森岡一朗, 米谷昌彦ほか:早産児の黄疸管理の現状と課題. 日本未熟児新生児学会雑誌 2014;26:57-66.
Medical*Online
2) Morioka I, Nakamura H, Koda T, et al:Current incidence of clinical kernicterus in preterm infants in Japan. Pediatr Int 2015;57:494-7.
PubMed
3) Morioka I, Nakamura H, Koda T, et al:Serum unbound bilirubin as a predictor for clinical kernicterus in extremely low birth weight infants at alate age in the neonatal intensive care unit. Brain Dev 2015;37:753-7.
 
4) 森岡 一朗, 岩谷 壮太, 香田 翼ほか:早産児の黄疸管理～新しい管理方法と治療基準の考案. 日本周産期・新生児医学会雑誌 2017;53:1-9.
Medical*Online
5) Morioka I, Nakamura H, Iwatani S, et al:International Perspetives:Clinical kernicterus in preterm in Japan. NeoReviews 2016;17:e124-30.
 
P.199 掲載の参考文献
1) Kawade N, Onishi S:The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J 1981;196:257-60.
PubMed
2) Shapiro SM:Chronic bilirubin encephalopathy:diagnosis and outcome. Semin Fetal Neonatal Med 2010;15:157-63.
PubMed
3) Okumura A, Kidokoro H, Shoji H, et al:Kernicterus in preterm infants. Pediatrics 2009;123:e1052-8.
PubMed
4) Morioka I, Nakamura H, Iwatani S, et a1:Clinical kernicterus in preterm infants in Japan. NeoReviews 2016;17:e124-30.
 
5) Nambara T, Katayama Y, Enomoto M, et al:Reliability of total bilirubin measurements in whole blood from preterm neonates using a blood gas analyzer. Clin Lab 2016;62:2285-9.
PubMed
6) Kurokawa D, Nakamura H, Yokota T, et al:Screening for hyperbilirubinemia in Japanese very low birthweight infants using transcutaneous bilirubinometry. J Pediatr 2016;168:77-81.
PubMed
7) 村田文也, 井村総一ほか:新生児高ビリルビン血症の光線療法. 小児外科・内科 1973;5:301.
 
8) 神戸大学医学部小児科 編:新版未熟児新生児の管理 第4版. 日本小児医事出版, 東京, 2000.
 
P.203 掲載の参考文献
1) 鈴木昭子, 中村友彦, 小宮山淳, ほか:超低出生体重児の上気道常在細菌叢と口腔内母乳塗布のMRSA保菌への影響. 日本小児科学会雑誌 2003;107:480-3.
 
2) 日本化学療法学会, 日本感染症学会, 日本環境感染学会ほか;8学会合同抗微生物薬適正使用推進検討委員会:抗菌薬適正 使用支援プログラム実践のためのガイダンス. 2017. http://www.kansensho.or.jp/guidelines/pdf/1708_ASP_guidance.pdf
 
P.207 掲載の参考文献
1) Josephson CD, Caliendo AM, Easley KA, et al:Blood Transfusion and Breast Milk Transmission of Cytomegalovirus in Very Low-Birth-Weight Infants. JAMA Pediatr 2014;168:1054. Available from:http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/jamapediatrics.2014.1360
 
2) Lanzieri TM, Dollard SC, Josephson CD, et al:Breast Milk -Acquired Cytomegalovirus Infection and Disease in VLBW and Premature Infants. Pediatrics 2013;131:e1937-45.
PubMed
3) Kelly MS, Benjamin DK, Puopolo KM, et al:Postnatal Cytomegalovirus Infection and the Risk of Bronchopulmonary Dysplasia. JAMA Pediatr 2015;169:e153785.
PubMed
4) 森内浩幸:先天性CMV感染治療プロトコール. 小児感染免疫 2011;22:385-9.
 
5) Omarsdottir S, Casper C, Naver L, et al:Cytomegalovirus Infection and Neonatal Outcome in Extremely Preterm Infants After Freezing of Maternal Milk. Pediatr Infect Dis J 2015;34:482-9. Available from:http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-201505000-00005
 
6) Hamprecht K, Maschmann J, Muller D, et al:Cytomegalovirus (CMV) inactivation in breast milk:Reassessment of pasteurization and freeze-thawing. Pediatr Res 2004;56:529-35.
PubMed
7) Bevot A, Hamprecht K, Krageloh-Mann I, et al:Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk. Acta Paediatr 2012;101:e167-72. Available from:http://www.ncbi.nlm.nih.gov/pubmed/22111513
 
8) Lopes A-A, Belhabri S, Karaoui L:Clinical Findings and Autopsy of a Preterm Infant with Breast Milk-Acquired Cytomegalovirus Infection. Am J Perinatol Reports 2016;6:e198-202. Available from:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0035-1566249
 
P.212 掲載の参考文献
1) Mohsen AH, Kamel BA:Predictive values for procalcitonin in the diagnosis of neonatal sepsis. Electron physician 2015;7:1190-5. Available from:http://www.ncbi.nlm.nih.gov/pubmed/26396733
 
2) 鈴木昭子, 中村友彦, 小宮山淳, ほか:超低出生体重児の上気道常在細菌叢と口腔内母乳塗布のMRSA保菌への影響. 日本小児科学会雑誌 2003;107:480-3.
 
P.215 掲載の参考文献
1) 阿部世紀, 庄司康寛, 佐藤公則, ほか:小児重症急性細気管支炎に対するheliox吸入療法パイロットスタディ. 日集中医誌 2016;23:633-40.
 
P.221 掲載の参考文献
1) Cayabyab R, Ramanathan R:Retinopahty of prematurity:Therapeutic strategies based on pathophysiology. Neonatology 2016;109:369-76.
 
2) MacDonald MG, Seshia MMK:Retinopathy of prematurity. In;Avery's Neonatology Pathophysiology and management of the newborn 7th ed, p1069, Wolters Kluwer, Philadelphia, 2016.
 
3) 改訂3版 超低出生体重児 新しい管理指針. 仁志田博司, 楠田聡 編, メジカルビュー社, 東京, 2006, p131.
 
4) Felson WM;American Academy of Pediatrics Section on Ophthalmology;American Academy of Ophthalmology;American association for Pediatric Ophthalmology and Strabismus;American Association of Certified Orthoptists:Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013;131:189-95.
 
5) Carlo WA, Finner NN, Walsh MC, et al;SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network:Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010;362:1959-69.
 
6) Vaucher YE, perala-Carcelem M, Finer NN, et al;SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network:Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med 2012;367:2495-504.
 
7) The BOOST-II Australia and United Kingdom Collaborative Groups:Outcomes of two trials of oxygen-saturation targets in preterm infants. N Engl J Med 2016;374:749-60.
PubMed
8) Askie LM, Darlow BA, Davis PG, et al:Effect of targeting lower versus higher arterial oxygen saturation on death or disability in preterm infants. Cochrane Database Syst Rev 2017;4:CD011190.
PubMed
9) Cayabyab R, Ramanathan R:Retinopahty of prematurity:Therapeutic strategies based on pathophysiology. Neonatology 2016;109:369-76.
 
10) Mintz-Hittner HA, Kennedy KA, Chuang AZ;BEAT-ROP Cooperative Group:Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011;364:603-15.
PubMed
11) Morin J, Luu TM, Superstein R, et al;Canadian Neonatal Network and the Canadian Neonatal Follow-Up Network Investigators:Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity. Pediatrics 2016;137:e20153218.
 
12) Buhrer C, Bassler D:Oral propranolol:a new treatment in infants with retinopathy of prematurity. Neonatology 2015;108:49-52.
PubMed
13) Kandasamy Y, Numar P, Hartley L:The effect of erythropoietin on the severity of retinopathy of prematurity. Eye 2014;28:814-8.
 
14) Xu XJ, Huang HY, Chen HI:Erythropoietin and retinopathy of prematurity:a meta-analysis. Eur J Pediatr 2014;173:1355-64.
 
P.225 掲載の参考文献
1) Holbrook KA:A histological comparison of infant and adult skin. In;Neonatal skin:structure and function, Maibach HI, Boisits EK (eds), New York, M. Dekker, 1982, 3-31.
 
2) Nonato LB, et al:Evolution of skin barrier function in premature neonates. Unpublished doctoral dissertation, University of California, Berkeley, UMI Publication, 1998.
 
3) Evans NJ, Rutter N:Development of the epidermis in the newborn. Biol Neonate 1986;49:74-80.
PubMed
4) Harpin VA, Rutter N:Humidification of incubators. Arch Dis Child 1985;60:219-24.
PubMed
5) Sedin G, Hammarlund K, Nilsson GE, et al:Measurements of transepidermal water loss in newborn infants. Clinics in perinatology 1985;12:79-99.
PubMed
6) Kalia YN, Nonato LB, Lund CH, et al:Development of skin barrier function in premature infants. J Invest Dermatol 1998;111:320-6.
PubMed
7) Dietel K:Morphological and functional development of the skin. In;Perinatal physiology 2nd ed, Uwe S eds, New York, Plenum Medical, 1978, pp.761-73.
 
8) Peck SM, Botwinick IS:The buffering capacity of infants' skins against an alkaline soap and neutral detergent. J Mt Sinai Hosp NY 1964;31:134-7.
 
9) Fox C, Nelson D, Wareham J:The timing of skin acidification in very low birth weight infants. J Perinatol 1998;18:272-5.
PubMed
10) Friedman Z:Essential fatty acids revisited. Am J Dis Child 1980;134:397-408.
PubMed
11) Esterly N, et al:Neonatal skin probrems. In;Dermatology 2nd ed. Hurley HJ, Moschella SL, eds Philadelphia, Saunders, 1985, 1882-903.
 
12) 板橋家頭夫, 上谷良行, 小川雄之亮:極低出生体重児の亜鉛欠乏に関する前方視的検討. 日本新生児学会雑誌 2001;37:186.
 
P.229 掲載の参考文献
1) Yu Y, Flint AF, Mulliken JB, et al:Endothelial progenitor cells in infantile hemangioma. Blood 2004;103:1373-5.
PubMed
2) Jinnin M, Medici D, Park L, et al:Suppressed NFATdependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 2008;14:1236-46.
PubMed
3) Hidano A, Purwoko R, Jitsukawa K:Statistical survey of skin changes ill Japanese neonates. Pediatr Dermatol 1986;3:140-4.
 
4) Sundine MJ, Wirth GA:Hemangiomas:an overview. Clin Pediatr(Phila)2007;46:206-21.
PubMed
5) Drolet BA, Swanson EA, Frieden IJ:Hemangioma Investigator Group. Infantile hemangiomas:an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 2008;153:712-5.
 
6) Kanada KN, Merin MR, Munden A, et al:Prospective study of cutaneous findings in newborns in the United States:correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr 2012;161:240-5.
PubMed
7) Garzon MC, Drolet BA, Baselga E, et al:Comparison of infantile hemangiomas in preterm and term infants:a prospective study. Arch Dermatol 2008;144:1231-2.
PubMed
8) Enjolras O, Riche MC, Merland JJ, et al:Management of alarming hemangiomas in infancy:a review of 25 cases. Pediatrics1990;85:491-8.
PubMed
9) Moukaddam H, Pollak J, Haims AH:MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol 2009;38:535-47.
PubMed
10) 血管腫・血管奇形・リンパ管奇形診療ガイドライン2017. 平成26-28年度厚生労働科学研究費補助金難治性疾患等政策研究事業(難治性疾患政策研究事業)「難治性血管腫・血管奇形・リンパ管腫・リンパ管腫症および関連疾患についての調査研究」班 編, 2017. http://www.marianna-u.ac.jp/va/files/vascular%20anomalies%20practice%20guideline%202017.pdf#view=FitV
 
11) Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al:Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51.
PubMed
12) Rangmar Goelz, Christian F Poets:Incidence and treatment of infantile haemangioma in preterm infants. Arch Dis Child Fetal Neonatal Ed 2015;100:F85-F91
 
13) Erbay A, Sarialioglu F, Malbora B, et al:Propranolol for infantile hemangiomas:a preliminary report on efficacy and safety in very low birth weight infants. Turk J Pediatr 2010;52:450-6.
PubMed
14) ヘマンジオル(R) シロップ小児用0.375% 適正使用情報. https://www.maruho.co.jp/medical/hemangiol/proper-use/before/confirm.html
 
P.234 掲載の参考文献
1) 木原秀樹:ポジショニングとハンドリング. 赤ちゃんにやさしい発達ケア ディベロプメンタルケアとリハビリテーションがいちからわかる本. メディカ出版, 大阪, 2015, 64-80.
 
2) 木原秀樹:新生児のポジショニングノート. メディカ出版, 大阪, 2013.
 
3) 山田恭聖:新生児の皮膚構造. 八田恵理編, 新生児の皮膚ケアハンドブック. メディカ出版, 大阪, 2013, 8-13.
 
4) 八田恵理:超低出生体重児の皮膚とケアのポイント 全身のスキントラブルマップ. メディカ出版, 大阪, 2013, 16-20.
 
P.244 掲載の参考文献
1) Isayama T, Lee SK, Yang J, et al:Revisiting the Definition of Bronchopulmonary Dysplasia:Effect of Changing Panoply of Respiratory Support for Preterm Neonates. JAMA Pediatr 2017;171:271-9.
PubMed
2) Jobe AH, BancalariE:Bronchopulmonary dysplasia. Am J Rev Respir Crit Care Med 2001;163:1723-9.
 
3) Ehrenkranz RA, Walsh MC, Vohr BR, et al:Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia. Pediatrics 2005;116:1353-60.
PubMed
4) 中西秀彦, 日下 隆:本邦からの情報発信による国際貢献-臨床情報の国際標準化-. 日本新生児成育医学会雑誌 2018;30:254 -8.
 
5) Walsh MC, Yao Q, Gettner P, et al:Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004;114:1305-11.
PubMed
6) Ramel SE, Demerath EW, Gray HL, et al:The relationship of poor linear growth velocity with neonatal illness and two-year neurodevelopment in preterm infants. Neonatology 2012;102:19-24.
 
7) Simon L, Theveniaut C, Flamant C, et al:In Preterm Infants, Length Growth below Expected Growth during Hospital Stay Predicts Poor Neurodevelopment at 2 Years. Neonatology 2018;114:135-41.
PubMed
8) Terrin G, Berni Canani R, Di Chiara M, et al:Zinc in Early Life:A Key Element in the Fetus and Preterm Neonate. Nutrients 2015;7:10427-46.
PubMed
9) Niwa F, Kawai M, Kanazawa H, et al:Hyperthyrotropinemia at 2 weeks of age indicates thyroid dysfunction and predicts the occurrence of delayed elevation of thyrotropin in very low birth weight infants. Clin Endocrinol 2012;77:255-61.
PubMed
10) Chung HR, Shin CH, Yang SW, et al:High incidence of thyroid dysfunction in preterm infants. J Korean Med Sci 2009;24:627-31.
PubMed
11) Fernbach SK, Maizels M, Conway JJ:Ultrasound grading of hydronephrosis:introduction to the system used by the Society for Fetal Urology. Pediatr Radiol 1993;23:478-80.
 
P.248 掲載の参考文献
1) 和田雅樹:NICU からの退院支援とっておきノート. NEONATAL CARE 2018;31(12).
Medical*Online
2) NEONATAL CARE 2013年秋季増刊 NICUから始める退院調整&在宅ケアガイドブック. 前田浩利, 岡野恵里香 編, メディカ出版, 大阪, 2013.
 
3) NICUにおける地域連携・退院調整. 小児看護 2013;36(12)
 

[IV] 症例から考える管理

P.255 掲載の参考文献
1) Nakamura T, Yonemoto N, Nakayama M, et al:Early inhaled steroid use in extremely low birthweight infants:a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed;2016;101:F552-6.
PubMed
2) Lee J, Kim H-S, Jung YH, et al:Non-invasive neurally adjusted ventilatory assist in preterm infants:a randomised phase II crossover trial. Arch Dis Child Fetal Neonatal Ed 2015;100:507-13.
 
P.258 掲載の参考文献
1) 平野慎也, 藤村正哲, 楠田聡, ほか:超低出生体重児の脳室内出血および動脈管開存症の発症予防(ランダム化比較試験). 日本小児臨床薬理学会雑誌 2007;20:98-102.
 
P.261 掲載の参考文献
1) Kinsella JP, Steinhorn RH, Krishnan US, et al:Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. J Pediatr 2016;170:312-4.
PubMed
2) Aikio O, Metsola J, Vuolteenaho R, et al:Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure. J Pediatr 2012;161:397-403.
PubMed
P.289 掲載の参考文献
1) Morioka I, Nakamura H, Koda T, et al:Serum unbound bilirubin as a predictor for clinical kernicterus in extremely low birth weight infants at alate age in the neonata intensive care unit. Brain Dev 2015;37:753-7.
 
2) Nambara T, Katayama Y, Enomoto M, et al:Reliability of total bilirubin measurements in whole blood from preterm neonates using a blood gas analyzer. Clin Lab 2016;62:2285-9.
PubMed
3) 森沢 猛, 米谷昌彦, 小寺孝幸, ほか:新生児血液型不適合溶血性黄疸におけるCOHbの検討. 日本未熟児新生児学会雑誌 2012;24:73-7.
 
4) Aydemir O, Soysaldi E, Kale Y, et al:Body temperature changes of newborns under fluorescent versus LED phototherapy. Indian J Pediatr. 2014;81:751-4.
PubMed
P.294 掲載の参考文献
1) Milstone AM, Reich NG, Advani S, et al:Catheter Dwell Time and CLABSIs in Neonates With PICCs:A Multicenter Cohort Study. Pediatrics 2013;132:e1609-15.
PubMed

[V] フォローアップと予後

P.306 掲載の参考文献
1) Ishii N, Kono Y, Yonemoto N, et al:Neonatal Research Network, Japan:Outcomes of infants born at 22 and 23 weeks' gestation. Pediatrics 2013;132:62-71
 
P.345 掲載の参考文献
1) 厚生労働科学研究「周産期ネットワーク:フォローアップ研究」班:ハイリスク児のフォローアップマニュアル 小さく生まれた子どもたちへの支援, 三科 潤, 河野由美 編, メジカルビュー社, 東京, 2007.
 
2) 生澤雅夫 編:新版K式発達検査法 発達検査の考え方と使い方, 嶋津峯眞 監, ナカニシヤ出版, 京都, 1985.
 
3) Wechsler D(2003). Wechsler Intelligence Scale for Children-Forth Edition. Pearson. (=2010, 上野一彦, 藤田和弘, 前川久男ほか;日本版WISC-IV刊行委員会訳, 『日本版WISC-IV 理論・解釈マニュアル』, 東京, 日本文化科学社)
 

書評

最近チェックした商品履歴

Loading...